Search - tctmd.com

Displaying 621 - 640 of 835

Sort: Relevancy | Date

Presentation TCT 2016

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Dominick J. Angiolillo

November 01, 2016

Presentation TCT 2016

Should the Sequence Be: FFR-PCI-OCT? FFR-PCI-IVUS? Just FFR or just IVUS/OCT? And When Is Angiography Enough?

Presenter: Ik-Kyung Jang, Matthew J. Price, Seung-Jung Park

October 31, 2016

Presentation TCT 2016

When There Are No Revascularization Options: Indications and Evidence for the Coronary Sinus Reducer in the CHIP Patient

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Gregg W. Stone

October 31, 2016

Presentation TCT 2016

Italy Presents: How I Managed This Case

Presenter: Ariel Finkelstein, Ugo Limbruno, Giovanni Esposito

October 31, 2016

Presentation TCT 2016

Case Presentation: Difficult DAPT Duration Decision After PCI

Presenter: Alejandro Cherro, Anibal A. Damonte, Alfredo E. Rodriguez, Marcelo Bettinotti

October 31, 2016

Presentation TCT 2016

How to Treat Diffuse Disease With Current PCI Devices

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Corrado Tamburino

October 31, 2016

Presentation TCT 2016

Imaging Evaluation During PCI: Prediagnostic Value and Post Optimization

Presenter: Seung-Jung Park, Alan C. Yeung, Akiko Maehara

October 31, 2016

Presentation TCT 2016

Italy Responds: How Would I Treat?

Presenter: Ariel Finkelstein, Ugo Limbruno

October 31, 2016

Presentation TCT 2016

Israel Responds: How Would I Treat?

Presenter: Ariel Finkelstein, Ugo Limbruno, Haim Danenberg

October 31, 2016

Presentation TCT 2016

Managing the Post-Surgical and Surgical Turndown Patients: The Emerging Role of Complex PCI Strategies

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Gennaro Sardella

October 31, 2016

Presentation TCT 2016

Outcome-Derived FFR Threshold for Revascularization: Data From the IRIS FFR Registry (N=7,013)

Presenter: Seung-Jung Park, Alan C. Yeung, Jung-Min Ahn

October 31, 2016

Presentation TCT 2016

Italy Presents: Case 4 Introduction A Complication of Primary PCI during STEMI

Presenter: Ariel Finkelstein, Ugo Limbruno, Giovanni Esposito

October 31, 2016

Presentation TCT 2016

2016 Treatment of Saphenous Vein Grafts, Including Management of Acute Occlusions

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Joseph P. Carrozza Jr

October 31, 2016

Presentation TCT 2016

FFR-Guided Decision Making Is Now Standard

Presenter: Seung-Jung Park, Alan C. Yeung, Nico H.J. Pijls

October 31, 2016

Presentation TCT 2016

Case 2: Complex PCI

Presenter: Jun-Jack Cheng, Gary S. Mintz, Chiung Jen Wu, Hsiu-Yu Fang

October 31, 2016

Presentation TCT 2016

Should Every CTO Be Opened? From the IRIS-CTO Registry to the Randomized (DECISION-CTO Trial)

Presenter: Seung-Jung Park, Alan C. Yeung, Seung-Whan Lee

October 31, 2016

Presentation TCT 2016

Calcium Disruption With Coronary Lithoplasty. Use of the SHOCKWAVE Balloon in Complex Disease

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Ian T. Meredith

October 31, 2016

Presentation TCT 2016

Importance of Calcification on PCI Techniques and Outcomes: The Costs of Atherectomy-Regret

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Philippe Généreux

October 31, 2016

Presentation TCT 2016

Israel Responds: How Would I Treat?

Presenter: Ariel Finkelstein, Ugo Limbruno, Haim Danenberg

October 31, 2016

Presentation TCT 2016

What Really Matters in Bifurcation PCI? Technique or Concept

Presenter: Seung-Jung Park, Alan C. Yeung, Duk-Woo Park

October 31, 2016

Advertisement

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

Should the Sequence Be: FFR-PCI-OCT? FFR-PCI-IVUS? Just FFR or just IVUS/OCT? And When Is Angiography Enough?

When There Are No Revascularization Options: Indications and Evidence for the Coronary Sinus Reducer in the CHIP Patient

Italy Presents: How I Managed This Case

Case Presentation: Difficult DAPT Duration Decision After PCI

How to Treat Diffuse Disease With Current PCI Devices

Imaging Evaluation During PCI: Prediagnostic Value and Post Optimization

Italy Responds: How Would I Treat?

Israel Responds: How Would I Treat?

Managing the Post-Surgical and Surgical Turndown Patients: The Emerging Role of Complex PCI Strategies

Outcome-Derived FFR Threshold for Revascularization: Data From the IRIS FFR Registry (N=7,013)

Italy Presents: Case 4 Introduction A Complication of Primary PCI during STEMI

2016 Treatment of Saphenous Vein Grafts, Including Management of Acute Occlusions

FFR-Guided Decision Making Is Now Standard

Case 2: Complex PCI

Should Every CTO Be Opened? From the IRIS-CTO Registry to the Randomized (DECISION-CTO Trial)

Calcium Disruption With Coronary Lithoplasty. Use of the SHOCKWAVE Balloon in Complex Disease

Importance of Calcification on PCI Techniques and Outcomes: The Costs of Atherectomy-Regret

Israel Responds: How Would I Treat?

What Really Matters in Bifurcation PCI? Technique or Concept

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content